Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenSky Ventures is a Toronto-based venture capital and private equity firm founded in 2010 that invests primarily in early-stage Canadian B2B startups across sectors such as information technology, clean technology, SaaS, artificial intelligence, pharmaceuticals, enterprise software, and medical/life sciences. The fund has raised over $70 million across six funds as of 2024 and has invested in more than 30 startups. Notable exits include Akira Health and Cyclica. The firm's leadership brings expertise from tech, law, finance, and entrepreneurship[3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenSky Ventures.